In two lines and two minutes: Garudastra Aero makes aircraft components, has an order backlog of Rs 6,000 crore against Rs 1,500 crore of revenue, a 21% EBITDA margin and trades at 55 times earnings. Give the thesis and the one risk that breaks it.

Line one: Garudastra has four years of revenue already signed and earns 21% margins on it, so its growth is visible. Line two: at 55 times, the price assumes it converts that backlog fast, so the bet is on execution, not demand. The risk that breaks it is delivery slipping: at 12% earnings growth instead of 25%, and a multiple settling at 35, the shares would be roughly flat over four years.

A tailor with orders booked for the next four years does not worry about finding customers; the worry is whether the shop can sew fast enough. A backlog of Rs 6,000 crore against Rs 1,500 crore of revenue is 4 years of work already signed, so the demand question is largely answered. What the backlog cannot tell you is how fast it turns into revenue, because aircraft parts are delivered to schedules set by the customer, need certification, and depend on special materials.

Because the price already assumes a lot of growth. For the shares to compound at 10% a year for four years while the P/E falls from 55 to a more ordinary 35, earnings must grow about 23% a year. That is the hurdle. A company converting a large backlog at 21% margins can plausibly grow that fast, which is the thesis. But the multiple leaves little room: at 12% earnings growth, the same fall in the P/E leaves the shares +0% over four years, roughly flat.

A two-line thesis has a fixed shape: what the business has that others do not, and why the price does or does not already reflect it. Line one: four years of signed revenue at 21% margins makes Garudastra's growth unusually visible. Line two: at 55 times, the market is paying for that visibility in advance, so the shares work only if the backlog is delivered on schedule. The risk that breaks it: execution speed. Name its sources: capacity additions that run late, a certification delay on a new part, or a shortage of aerospace-grade alloys.

Two things make the answer stronger in the follow-up. Say what you would check: the backlog's delivery schedule by year, whether it is concentrated in one customer, and whether the company has the machines and certified staff to grow 20% to 25% a year. And say what would change your view: a quarter of revenue below the delivery schedule is the first sign the thesis is breaking, long before the backlog itself shrinks. The figures here are illustrative, and the view is about an invented company, not a forecast.